Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia–reperfusion injury by 3′,4′-dihydroxyflavonol-Reference-Cited by-同舟云学术

Evidence that the MEK/ERK but not the PI3K/Akt pathway is required for protection from myocardial ischemia–reperfusion injury by 3′,4′-dihydroxyflavonol

Published:2015-07 Issue: Volume:758 Page:53-59
ISSN:0014-2999
Container-title:European Journal of Pharmacology
language:en
Short-container-title:European Journal of Pharmacology

Author:

Thomas Colleen J.,Lim Nicholas R.,Kedikaetswe Alphious,Yeap Yvonne Y.,Woodman Owen L.,Ng Dominic C.H.,May Clive N.

Publisher

Elsevier BV

Subject

Pharmacology

Reference32 articles.

1. Role of the JAK–STAT pathway in myocardial injury;Barry;Trends Mol. Med.,2007

2. Inhibition of permeability transition pore opening by mitochondrial STAT3 and its role in myocardial ischemia/reperfusion;Boengler;Basic Res. Cardiol.,2010

3. Myocardial reperfusion: a double-edged sword?;Braunwald;J. Clin. Investig.,1985

4. Mitochondrial contribution in the progression of cardiac ischemic injury;Di Lisa;IUBMB Life,2001

5. Luteolin inhibits apoptosis and improves cardiomyocyte contractile function through the PI3K/Akt pathway in simulated ischemia/reperfusion;Fang;Pharmacology,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apoptosis of hippocampus and cerebellum induced with brain ischemia reperfusion prevented by 3’,4’-dihydroxyflavonol (DiOHF);Biotechnic & Histochemistry;2024-06-28

2. CaMKII, ‘jack of all trades’ in inflammation during cardiac ischemia/reperfusion injury;Journal of Molecular and Cellular Cardiology;2023-11

3. Effects of Mitochondrial ATP-Sensitive Potassium Channel in Rats with Acute Myocardial Infarction and Its Association with the AKT/mTOR Pathway;The Anatolian Journal of Cardiology;2023

4. Tanshinone IIA inhibits cardiomyocyte apoptosis and rescues cardiac function during doxorubicin-induced cardiotoxicity by activating the DAXX/MEK/ERK1/2 pathway;Phytomedicine;2022-12

5. NP202 treatment improves left ventricular systolic function and attenuates pathological remodelling following chronic myocardial infarction;Life Sciences;2022-01